Xiaoying Wu

Prof. Xiaoying Wu


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJuanni Li
Juanni Li
KHKuan Hu
Kuan Hu
GGGuanghui Gong
Guanghui Gong
DZDing Zhu
Ding Zhu
YWYixuan Wang
Yixuan Wang
XWXiaoying Wu
Xiaoying Wu
MicroRNAs (miRNAs) function as critical regulators of gene expression and their deregulation is associated with the development and progression of various cancers. This study aimed to investigate the biological role and mechanism of miR-205 in ovarian cancer (OC). MiR-205 was upregulated in OC tissues and cells in comparison to the controls. Meanwhile, overexpression of miR-205 was significantly associated with poor overall survival of OC patients. Functional study indicated that ectopic expression of miR-205 significantly promoted cell proliferation, migration, invasion and chemoresistance of OC cells. SMAD4 and PTEN were identified as direct targets of miR-205 using luciferase reporter assays, real-time PCR (qRT-PCR), and western blot. Most interestingly,in vivostudies indicated that miR-205 markedly promoted the growth and metastasis of tumors and the expression of miR-205 was also found to be inversely correlated with that of SMAD4 and PTEN in nude mice. Overall, we suggest that miR-205 functions as an oncogenic miRNA by directly binding to SMAD4 and PTEN, providing a novel target for the molecular treatment of ovarian cancer.

9 November 2015 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
HTHong Tan
Hong Tan
QHQingnan He
Qingnan He
GGGuanhui Gong
Guanhui Gong
YWYixuan Wang
Yixuan Wang
JLJuanni Li
Juanni Li
XWXiaoying Wu
Xiaoying Wu
Increasing evidence suggests that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miR‑382 has been observed in various types of cancers. However, the biological function of miRNA-382 in ovarian cancer is still largely unknown. Here, we found miR‑382 was downregulated in human ovarian cancer tissues and cell lines. miR‑382 inhibited ovarian cancer cell proliferation, migration, invasion and the epithelial-mesenchymal transition (EMT). Furthermore, we identified receptor tyrosine kinase orphan receptor 1 (ROR1) as a target of miR‑382, and miR‑382 rescued the promotion effect of ROR1 on migration, invasion and EMT process in SKOV3 and COV434 cells. Collectively, these findings revealed that miR‑382 inhibits migration and invision by targeting ROR1 through regulating EMT in ovarian cancer, and might serve as a tumor suppressor in ovarian cancer.

1 April 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
JLJuanni Li
Juanni Li
LLLong Li
Long Li
ZLZexia Li
Zexia Li
GGGuanghui Gong
Guanghui Gong
PCPuxiang Chen
Puxiang Chen
XWXiaoying Wu
Xiaoying Wu

1 January 2019 in Gynecologic Oncology
Verified
Journal Article
Closed access
YWYixuan Wang
Yixuan Wang
JJJing Jiang
Jing Jiang
LHLiuqing He
Liuqing He
GGGuanghui Gong
Guanghui Gong
XWXiaoying Wu
Xiaoying Wu

1 February 2015 in Pathology - Research and Practice
Verified
Journal Article
Closed access
GGGuanghui Gong
Guanghui Gong
PCPuxiang Chen
Puxiang Chen
LLLong Li
Long Li
HTHong Tan
Hong Tan
JZJun Zhou
Jun Zhou
XWXiaoying Wu
Xiaoying Wu

12 August 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YWYixuan Wang
Yixuan Wang
QCQuan Chen
Quan Chen
DWDi Wu
Di Wu
QCQifeng Chen
Qifeng Chen
GGGuanghui Gong
Guanghui Gong
XWXiaoying Wu
Xiaoying Wu
Ovarian cancer is the most malignant gynecologic cancer. Previous studies found that lamin-A was associated with DNA damage repair proteins but the underlying mechanism remains unclear. We speculate that this may be related to its interacting proteins, such as Hsp90. The aim of this study is to investigate the effects of Hsp90 on DNA damage repair and chemoresistance of ovarian cancer cells. In our research, co-immunoprecipitation (co-IP) and mass spectrometry (MS) were used to identify proteins interacting with lamin-A and the interaction domain. Next, the relationship between lamin-A and Hsp90 was explored by Western blotting (WB) and immunofluorescence staining. Then, effect of Hsp90 inhibition on DNA damage repair was assessed through detecting Rad50 and Ku80 by WB. Furthermore, to test the roles of 17-AAG on cell chemosensitivity, CCK-8 and colony formation assay were carried out. Meanwhile, IC50 of cells were calculated, followed by immunofluorescence to detect DNA damage. At last, the mouse xenograft model was used in determining the capacity of 17-AAG and DDP to suppress tumor growth and metastatic potential. The results showed that lamin-A could interact with Hsp90 via the domain of lamin-A1-430. Besides, the distribution of Hsp90 could be affected by lamin-A. After lamin-A knockdown, Hsp90 decreased in the cytoplasm and increased in the nucleus, suggesting that the interaction between lamin-A and Hsp90 may be related to the nucleocytoplasmic transport of Hsp90. Moreover, inhibition of Hsp90 led to an obvious decrease in the expression of DSBs (DNA double-strand break) repair proteins, as well as cell proliferation ability upon DDP treatment and IC50 of DDP, causing more serious DNA damage. In addition, the combination of 17-AAG and DDP restrained the growth of ovarian cancer efficiently in vivo and prolonged the survival time of tumor-bearing mice.